B & T Capital Management Dba Alpha Capital Management Merck & Co., Inc. Transaction History
B & T Capital Management Dba Alpha Capital Management
- $508 Million
- Q4 2024
A detailed history of B & T Capital Management Dba Alpha Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, B & T Capital Management Dba Alpha Capital Management holds 39,372 shares of MRK stock, worth $3.76 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
39,372
Previous 37,332
5.46%
Holding current value
$3.76 Million
Previous $4.24 Million
7.62%
% of portfolio
0.77%
Previous 0.85%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,816Shares Held
1.86BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$23.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.24 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.65 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $242B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...